10 Recruiting Myeloid Malignancy Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceTop Recruiting Myeloid Malignancy Studies
🟢 Recruiting Observational / Diagnostic 📋 Clinical Research Protocol
Considering alloHCT: Opportunities for Patient Reflection During Decision-Making Via Digital Stories
📍 University of Rochester — Rochester, New York
View Study & Checklist ➔ 🟢 Recruiting Observational / Diagnostic 🩺 Clinical Procedure Protocol
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
View Study & Checklist ➔ 🟢 Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol
Germline Testing for Predisposition to Myeloid Malignancies
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Observational / Diagnostic 🧠 Behavioral & Psychological Program
A Telehealth Advance Care Planning Intervention
📍 University of Rochester — Rochester, New York
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
📍 Henry ford hospital — Detroit, Michigan
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant
📍 Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center — Cleveland, Ohio
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML
📍 Masonic Cancer Center — Minneapolis, Minnesota
View Study & Checklist ➔